NASDAQ:XERS | EBITDA Margin | Xeris Biopharma Holdings, Inc.

Complete source-backed ebitda margin history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-319.93%
2025-12-3119.94%
2025-03-31-4.62%
2024-12-313.31%
2024-03-31-34.25%
2023-12-31-21.39%
2023-03-31-38.90%
2022-12-31-44.67%
2022-03-31-130.26%
2021-12-31-223.63%
2021-03-31-203.74%
2020-12-31-266.57%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-318.98%
2024-12-31-15.96%
2023-12-31-25.94%
2022-12-31-73.05%
2021-12-31-229.54%
2020-12-31-407.24%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.